SGHERZA, N. (2021) “Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma”, Acta Biomedica Atenei Parmensis, 92(2), p. e2021205. doi:10.23750/abm.v92i2.11395.